Endonovo Therapeutics Statistics
Total Valuation
ENDV has a market cap or net worth of 241,323.
Market Cap | 241,323 |
Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, June 27, 2025.
Earnings Date | Jun 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ENDV has 1.21 billion shares outstanding.
Current Share Class | 1.21B |
Shares Outstanding | 1.21B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -77.91% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.94 |
PB Ratio | -0.01 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
Current Ratio | 0.00 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.15 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -144.27% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 11.44% |
Revenue Per Employee | 255,723 |
Profits Per Employee | -4.40M |
Employee Count | 1 |
Asset Turnover | 0.23 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.82% in the last 52 weeks. The beta is -1.96, so ENDV's price volatility has been lower than the market average.
Beta (5Y) | -1.96 |
52-Week Price Change | -81.82% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 51.50 |
Average Volume (20 Days) | 7,784,225 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, ENDV had revenue of 255,723 and -4.40 million in losses. Loss per share was -0.06.
Revenue | 255,723 |
Gross Profit | 246,034 |
Operating Income | -2.62M |
Pretax Income | -4.40M |
Net Income | -4.40M |
EBITDA | -1.97M |
EBIT | -2.62M |
Loss Per Share | -0.06 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | 7.06M |
Net Cash | -7.06M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | -22.96M |
Book Value Per Share | -0.07 |
Working Capital | -23.66M |
Cash Flow
Operating Cash Flow | -629,904 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 96.21% |
Operating Margin | -1,023.16% |
Pretax Margin | -1,722.23% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ENDV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -130.88% |
Shareholder Yield | n/a |
Earnings Yield | -1,825.00% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.001.
Last Split Date | Dec 20, 2019 |
Split Type | Reverse |
Split Ratio | 0.001 |
Scores
ENDV has an Altman Z-Score of -159.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -159.34 |
Piotroski F-Score | 4 |